Skip to main content

FDA recall, , Moderate risk

Tosoh ST AIA-Pack Testosterone Test

The test cup lot F level 1 low-quality control results were lower than expected, which could cause falsely elevated or falsely low total testosterone results.

What happened

Tosoh Bioscience Inc, of Grove City, Ohio, recalled the ST AIA-Pack Testosterone, an in vitro diagnostic used for the quantitative measurement of testosterone in human serum on specific Tosoh AIA System analyzers, Model Number 0025204.

The recall was initiated on June 12, 2026, because the Test cup lot F level 1 low-quality control results were lower than expected on the Automated Immunoassay Analyzer (AIA), which could cause falsely elevated or falsely low total testosterone results.

Such erroneous results may lead to additional testing or diagnostic interventions and, in limited cases, may delay diagnosis or cause unnecessary or incorrect clinical treatment.

The device was distributed nationwide in the United States. The recall was added to the FDA's Enforcement Report on July 16, 2026.

What to do

We don't have product-specific instructions for this recall. FDA's general advice for medical device recalls:

  1. A device recall doesn't always mean you must stop using it: it may need to be checked, adjusted or fixed.
  2. Talk to your health care provider before you stop using it.

Is yours affected?

Match the UDI-DI and lot code listed under your product.

A UDI-DI is the device identifier printed with the barcode on the device label.

  1. ST AIA-Pack Testosterone, In Vitro Diagnostic Use Only for the quantitative measurement of testosterone in human serum on specific Tosoh AIA System analyzers, Model Number 0025204

    UDI-DI
    • 14560189210032
    Lot code
    • FX12404
    • FY12407
    • FY12406
    • FZ12408

Recall details

Company began the recall
Sold in

Global Distribution. US Nationwide.

Company
Tosoh Bioscience IncGrove City, Ohio
Risk

Moderate risk

Using it may cause short-term health problems, or ones that treatment can reverse. Serious harm is unlikely.

FDA Class II recall · How risk is rated

Event ID
99210
Recall number
Z-2746-2026
Quantity recalled
310 units

Timeline

FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.

  1. Company began the recall

  2. Added to FDA's Enforcement Report · Classified by FDA

  3. Listed on Recall Canary

  4. In FDA's weekly enforcement report

  5. Summary updated

Summary by Recall Canary, written with AI · summary updated Oct 3, 2026 · primary source: U.S. Food and Drug Administration (opens in a new tab)